Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Robbins Arroyo LLP Is Investigating the Officers and Directors of Bio-Rad Laboratories, Inc. (BIO) on Behalf of Shareholders

BIO

SAN DIEGO & HERCULES, Calif., Nov. 4, 2014 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Bio-Rad Laboratories, Inc. (NYSE: BIO) breached their fiduciary duties to shareholders.  Bio-Rad manufactures and supplies products and systems used to separate complex chemical and biological materials, as well as to identify, analyze, and purify their components for life science research, healthcare, analytical chemistry, and other markets.

Robbins Arroyo LLP.

View this press release on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/bio-rad-laboratories-inc

U.S. Securities and Exchange Commission Charges Bio-Rad with Violating the Foreign Corrupt Practices Act

On November 3, 2014, the U.S. Securities and Exchange Commission and the U.S. Department of Justice charged Bio-Rad with making unlawful payments to government officials in violation of the Foreign Corrupt Practices Act. Specifically, Bio-Rad is charged with making unlawful payments to officials in Thailand and Vietnam between 2005 and 2010. The company was also charged with securing profitable public contracts in Russia by unlawfully paying commissions to intermediaries who passed along a portion of their commissions to Russian government officials.  According to the agencies, Bio-Rad paid approximately $7.5 million in bribes to officials in the three countries from 2005 to 2010 to obtain or retain business in those countries, enabling it to secure $35 million in illicit profits.  In conjunction with the charges, Bio-Rad has agreed to pay over $55 million to resolve the allegations.

In light of this news, Robbins Arroyo LLP is investigating whether Bio-Rad's board of directors breached its fiduciary duties to shareholders by failing to ensure that the company maintained compliance with the law. 

Bio-Rad Shareholders Have Legal Options

Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.

Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law.  The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested. 

Attorney Advertising. Past results do not guarantee a similar outcome.  

Contact:
Darnell R. Donahue
Robbins Arroyo LLP
600 B Street, Suite 1900
San Diego, Ca 92101
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com

Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO

SOURCE Robbins Arroyo LLP



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today